Atwood & Palmer’s DexCom DXCM Stock Holding History

Atwood & Palmer’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.7K	Hold	500	–	–	﹤0.01%	283
2026 Q1	$31.4K	Hold	500	–	–	﹤0.01%	279
2025 Q4	$33.2K	Hold	500	–	–	﹤0.01%	270
2025 Q3	$33.6K	Hold	500	–	–	﹤0.01%	280
2025 Q2	$43.6K	Hold	500	–	–	﹤0.01%	247
2025 Q1	$34.1K	Hold	500	–	–	﹤0.01%	251
2024 Q4	$38.9K	Hold	500	–	–	﹤0.01%	237
2024 Q3	$33.5K	Hold	500	–	–	﹤0.01%	252
2024 Q2	$56.7K	Sell	500 -23	-4%	-$2.91K	﹤0.01%	219
2024 Q1	$72.5K	Buy	523 +23	+5%	+$2.89K	0.01%	200
2023 Q4	$62K	Hold	500	–	–	0.01%	212
2023 Q3	$46.6K	Sell	500 -500	-50%	-$56.4K	﹤0.01%	215
2023 Q2	$129K	Sell	1,000 -1,000	-50%	-$121K	0.01%	173
2023 Q1	$232K	Hold	2,000	–	–	0.02%	131
2022 Q4	$226K	Hold	2,000	–	–	0.02%	139
2022 Q3	$161K	Hold	2,000	–	–	0.02%	145
2022 Q2	$149K	Hold	2,000	–	–	0.01%	151
2022 Q1	$256K	Hold	2,000	–	–	0.02%	133
2021 Q4	$268K	Hold	2,000	–	–	0.02%	134
2021 Q3	$273K	Hold	2,000	–	–	0.02%	133
2021 Q2	$214K	Hold	2,000	–	–	0.02%	142
2021 Q1	$180K	Hold	2,000	–	–	0.02%	148
2020 Q4	$185K	Hold	2,000	–	–	0.02%	140
2020 Q3	$206K	Hold	2,000	–	–	0.03%	127
2020 Q2	$203K	Hold	2,000	–	–	0.03%	125
2020 Q1	$135K	Hold	2,000	–	–	0.02%	135
2019 Q4	$109K	Hold	2,000	–	–	0.01%	154
2019 Q3	$75K	Sell	2,000 -2,000	-50%	-$77.7K	0.01%	175
2019 Q2	$150K	Hold	4,000	–	–	0.02%	138
2019 Q1	$119K	Hold	4,000	–	–	0.02%	146
2018 Q4	$120K	Hold	4,000	–	–	0.02%	141
2018 Q3	$143K	Hold	4,000	–	–	0.02%	138
2018 Q2	$95K	Hold	4,000	–	–	0.01%	156
2018 Q1	$74K	Hold	4,000	–	–	0.01%	165
2017 Q4	$57K	Buy	4,000 +2,000	+100%	+$26K	0.01%	178
2017 Q3	$24K	Hold	2,000	–	–	﹤0.01%	213
2017 Q2	$37K	Sell	2,000 -4,072	-67%	-$75.2K	0.01%	199
2017 Q1	$129K	Hold	6,072	–	–	0.02%	136
2016 Q4	$91K	Buy	6,072 +1,000	+20%	+$17.7K	0.02%	144
2016 Q3	$111K	Hold	5,072	–	–	0.02%	139
2016 Q2	$101K	Hold	5,072	–	–	0.02%	148
2016 Q1	$86K	Hold	5,072	–	–	0.02%	148
2015 Q4	$104K	Buy	5,072 +4,072	+407%	+$84.7K	0.02%	159
2015 Q3	$21K	Hold	1,000	–	–	﹤0.01%	266
2015 Q2	$20K	Hold	1,000	–	–	﹤0.01%	246
2015 Q1	$16K	Buy	+1,000	New	+$15.1K	﹤0.01%	247

Other funds holding DXCM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

FMI

Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Atwood & Palmer's DXCM Position: Q2 2026 in Review

Atwood & Palmer held its DexCom (DXCM) position steady in Q2 2026 at 500 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #283.

Atwood & Palmer first reported a position in DXCM in Q1 2015 and has held it in 46 quarters since. The position peaked at $273K in Q3 2021. 224 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Atwood & Palmer held 500 shares of DexCom worth $33.7K as of Q2 2026.
Atwood & Palmer left its DexCom share count unchanged in Q2 2026.
DexCom made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #283 holding.
Atwood & Palmer first reported a position in DexCom in Q1 2015 and has held it in 46 quarters since.
Atwood & Palmer's DexCom position peaked at $273K in Q3 2021.
224 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.